Your browser doesn't support javascript.
loading
B-cell repopulation dynamics and drug pharmacokinetics impact SARS-CoV-2 vaccine efficacy in anti-CD20-treated multiple sclerosis patients.
Asplund Högelin, Klara; Ruffin, Nicolas; Pin, Elisa; Hober, Sophia; Nilsson, Peter; Starvaggi Cucuzza, Chiara; Khademi, Mohsen; Olsson, Tomas; Piehl, Fredrik; Al Nimer, Faiez.
Afiliación
  • Asplund Högelin K; Neuroimmunology Unit, Department of Clinical Neuroscience, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Ruffin N; Neuroimmunology Unit, Department of Clinical Neuroscience, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Pin E; SciLifeLab, Department of Protein Science, KTH Royal Institute of Technology, Stockholm, Sweden.
  • Hober S; SciLifeLab, Department of Protein Science, KTH Royal Institute of Technology, Stockholm, Sweden.
  • Nilsson P; SciLifeLab, Department of Protein Science, KTH Royal Institute of Technology, Stockholm, Sweden.
  • Starvaggi Cucuzza C; Neuroimmunology Unit, Department of Clinical Neuroscience, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Khademi M; Neuroimmunology Unit, Department of Clinical Neuroscience, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Olsson T; Neuroimmunology Unit, Department of Clinical Neuroscience, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Piehl F; Neuroimmunology Unit, Department of Clinical Neuroscience, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Al Nimer F; Neuroimmunology Unit, Department of Clinical Neuroscience, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.
Eur J Neurol ; 29(11): 3317-3328, 2022 Nov.
Article en En | MEDLINE | ID: mdl-35808856
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 4_TD Problema de salud: 1_doencas_nao_transmissiveis / 2_enfermedades_transmissibles / 2_muertes_prematuras_enfermedades_notrasmisibles / 4_pneumonia Asunto principal: Linfocitos B / Vacunas contra la COVID-19 / COVID-19 / Esclerosis Múltiple Tipo de estudio: Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: Eur J Neurol Asunto de la revista: NEUROLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Suecia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 4_TD Problema de salud: 1_doencas_nao_transmissiveis / 2_enfermedades_transmissibles / 2_muertes_prematuras_enfermedades_notrasmisibles / 4_pneumonia Asunto principal: Linfocitos B / Vacunas contra la COVID-19 / COVID-19 / Esclerosis Múltiple Tipo de estudio: Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: Eur J Neurol Asunto de la revista: NEUROLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Suecia